Walsh M A, Bialkowski J, Szkutnik M, Pawelec-Wojtalik M, Bobkowski W, Walsh K P
Cardiac Department, Our Lady's Hospital for Sick Children, Crumlin, Dublin 8, Ireland.
Heart. 2006 Sep;92(9):1295-7. doi: 10.1136/hrt.2005.084988. Epub 2006 Jan 31.
To look at the presentation, treatment and outcome of patients who developed atrioventricular block after transcatheter closure of a perimembranous ventricular septal defect (PMVSD) with the Amplatzer PMVSD device.
Three tertiary referral centres for paediatric cardiology in two countries.
All three patients presented within 10 days of the procedure. All three patients were treated with intravenous steroids. A permanent pacemaker was inserted in all patients but no pacemaker required activation after two months.
Complete atrioventricular block occurring in the weeks after device occlusion of a PMVSD appears to resolve quickly. Continued involvement in multicentre device databases is required to monitor safety.
观察使用Amplatzer膜周部室间隔缺损(PMVSD)封堵器经导管封堵膜周部室间隔缺损后发生房室传导阻滞的患者的临床表现、治疗及结局。
两个国家的三个儿科心脏病学三级转诊中心。
所有三名患者均在术后10天内出现症状。所有三名患者均接受了静脉注射类固醇治疗。所有患者均植入了永久性起搏器,但两个月后均无需激活起搏器。
PMVSD封堵术后数周内发生的完全性房室传导阻滞似乎能迅速缓解。需要持续参与多中心器械数据库以监测安全性。